{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:44:20Z","timestamp":1772829860500,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/ncpgasthep0654","type":"journal-article","created":{"date-parts":[[2006,11,28]],"date-time":"2006-11-28T12:58:22Z","timestamp":1164718702000},"page":"680-688","source":"Crossref","is-referenced-by-count":14,"title":["Post-ERCP pancreatitis and its prevention"],"prefix":"10.1038","volume":"3","author":[{"given":"Carl D","family":"Frank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas G","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpgasthep0654_CR1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-2002-32004","volume":"34","author":"S Friedland","year":"2002","unstructured":"Friedland S  et al. (2002) Bedside scoring system to predict the risk of developing pancreatitis following ERCP. Endoscopy 34: 483\u2013488","journal-title":"Endoscopy"},{"key":"BFncpgasthep0654_CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mge.2001.117550","volume":"54","author":"ML Freeman","year":"2001","unstructured":"Freeman ML  et al. (2001) Risk factors for PEP: a prospective, multicenter study. Gastrointest Endosc 54: 425\u2013434","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1572-0241.2005.40638.x","volume":"100","author":"T Tsujino","year":"2005","unstructured":"Tsujino T  et al. (2005) Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation. Am J Gastroenterol 100: 38\u201342","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0654_CR4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1055\/s-2003-42614","volume":"35","author":"E Masci","year":"2003","unstructured":"Masci E  et al. (2003) Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 35: 830\u2013834","journal-title":"Endoscopy"},{"key":"BFncpgasthep0654_CR5","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1572-0241.1999.01072.x","volume":"94","author":"PA Testoni","year":"1999","unstructured":"Testoni PA  et al. (1999) Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis. Am J Gastroenterol 94: 1235\u20131241","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0654_CR6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0016-5107(02)70112-0","volume":"56","author":"J Vandervoort","year":"2002","unstructured":"Vandervoort J  et al. (2002) Risk factors for complications after performance of ERCP. Gastrointest Endosc 56: 652\u2013656","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1572-0241.2001.03594.x","volume":"96","author":"E Masci","year":"2001","unstructured":"Masci E  et al. (2001) Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96: 417\u2013423","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0654_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(98)70121-X","volume":"48","author":"S Loperfido","year":"1998","unstructured":"Loperfido S  et al. (1998) Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48: 1\u201310","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1055\/s-2002-35834","volume":"34","author":"M Barthet","year":"2002","unstructured":"Barthet M  et al. (2002) Complications of endoscopic sphincterotomy: results from a single tertiary referral center. Endoscopy 34: 991\u2013997","journal-title":"Endoscopy"},{"key":"BFncpgasthep0654_CR10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199609263351301","volume":"335","author":"ML Freeman","year":"1996","unstructured":"Freeman ML  et al. (1996) Complications of endoscopic biliary sphincterotomy. N Engl J Med 335: 909\u2013918","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0654_CR11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0016-5107(02)70351-9","volume":"56","author":"S Cohen","year":"2002","unstructured":"Cohen S  et al. (2002) National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy. Gastrointest Endosc 56: 803\u2013809","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5107(91)70740-2","volume":"37","author":"PB Cotton","year":"1991","unstructured":"Cotton PB  et al. (1991) Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37: 383\u2013393","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0016-5107(03)02876-1","volume":"59","author":"P Singh","year":"2004","unstructured":"Singh P  et al. (2004) Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis. Gastrointest Endosc 59: 499\u2013505","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/s-2002-23630","volume":"34","author":"E Christoforidis","year":"2002","unstructured":"Christoforidis E  et al. (2002) PEP and hyperamylasemia: patient-related and operative risk factors. Endoscopy 34: 286\u2013292","journal-title":"Endoscopy"},{"key":"BFncpgasthep0654_CR15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000200762","volume":"50","author":"R Laugier","year":"1991","unstructured":"Laugier R  et al. (1991) Changes in pancreatic exocrine secretion with age: pancreatic exocrine secretion does decrease in the elderly. Digestion 50: 202\u2013211","journal-title":"Digestion"},{"key":"BFncpgasthep0654_CR16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/0016-5085(88)90182-5","volume":"95","author":"M Guelrud","year":"1988","unstructured":"Guelrud M  et al. (1988) Effect of nifedipine on sphincter of Oddi motor activity: studies in healthy volunteers and patients with biliary dyskinesia. Gastroenterology 95: 1050\u20131055","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0654_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000201021","volume":"54","author":"J Sand","year":"1993","unstructured":"Sand J and Nordback I (1993) Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Digestion 54: 105\u2013111","journal-title":"Digestion"},{"key":"BFncpgasthep0654_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0016-5107(02)70178-8","volume":"56","author":"F Prat","year":"2002","unstructured":"Prat F  et al. (2002) Nifedipine for prevention of PEP: a prospective, double-blind randomized study. Gastrointest Endosc 56: 202\u2013208","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gut.26.2.194","volume":"26","author":"M Staritz","year":"1985","unstructured":"Staritz M  et al. (1985) Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure. Gut 26: 194\u2013197","journal-title":"Gut"},{"key":"BFncpgasthep0654_CR20","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0016-5085(85)90004-6","volume":"88","author":"M Staritz","year":"1985","unstructured":"Staritz M  et al. (1985) Endoscopic removal of common bile duct stones through the intact papilla after medical sphincter dilation. Gastroenterology 88: 1807\u20131811","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0654_CR21","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1046\/j.0007-1323.2001.01842.x","volume":"88","author":"S Sudhindran","year":"2001","unstructured":"Sudhindran S  et al. (2001) Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 88: 1178\u20131182","journal-title":"Br J Surg"},{"key":"BFncpgasthep0654_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mge.2003.29","volume":"57","author":"M Moreto","year":"2003","unstructured":"Moreto M  et al. (2003) Transdermal glyceryl trinitrate for prevention of PEP: a randomized double-blind trial. Gastrointest Endosc 57: 1\u20137","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0016-5107(03)02540-9","volume":"59","author":"JJ Schwartz","year":"2004","unstructured":"Schwartz JJ  et al. (2004) The effect of lidocaine sprayed on the major duodenal papilla on the frequency of PEP. Gastrointest Endosc 59: 179\u2013184","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0016-5107(85)72018-4","volume":"31","author":"BF Hannigan","year":"1985","unstructured":"Hannigan BF  et al. (1985) Hyperamylasemia after ERCP with ionic and non-ionic contrast media. Gastrointest Endosc 31: 109\u2013110","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2007-1013018","volume":"19","author":"WJ Cunliffe","year":"1987","unstructured":"Cunliffe WJ  et al. (1987) A randomised, prospective study comparing two contrast media in ERCP. Endoscopy 19: 201\u2013202","journal-title":"Endoscopy"},{"key":"BFncpgasthep0654_CR26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0016-5107(95)70128-1","volume":"42","author":"GK Johnson","year":"1995","unstructured":"Johnson GK  et al. (1995) A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc 42: 312\u2013316","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5107(94)70204-7","volume":"40","author":"S Sherman","year":"1994","unstructured":"Sherman S  et al. (1994) PEP: randomized, prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc 40: 422\u2013427","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1091-255X(01)80059-7","volume":"5","author":"S Raty","year":"2001","unstructured":"Raty S  et al. (2001) Post-ERCP pancreatitis: reduction by routine antibiotics. J Gastrointest Surg 5: 339\u2013345","journal-title":"J Gastrointest Surg"},{"key":"BFncpgasthep0654_CR29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0016-5107(94)70247-0","volume":"40","author":"C Niederau","year":"1994","unstructured":"Niederau C  et al. (1994) Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc 40: 533\u2013537","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF03348276","volume":"3","author":"MH Vatn","year":"1980","unstructured":"Vatn MH  et al. (1980) A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man. J Endocrinol Invest 3: 279\u2013282","journal-title":"J Endocrinol Invest"},{"key":"BFncpgasthep0654_CR31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0016-5107(99)70387-1","volume":"49","author":"RT Poon","year":"1999","unstructured":"Poon RT  et al. (1999) Prophylactic effect of somatostatin on PEP: a randomized controlled trial. Gastrointest Endosc 49: 593\u2013598","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR32","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/gut.52.12.1768","volume":"52","author":"RT Poon","year":"2003","unstructured":"Poon RT  et al. (2003) Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Gut 52: 1768\u20131773","journal-title":"Gut"},{"key":"BFncpgasthep0654_CR33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1746.2003.03297.x","volume":"19","author":"D Arvanitidis","year":"2004","unstructured":"Arvanitidis D  et al. (2004) Can somatostatin prevent PEP? Results of a randomized controlled trial. J Gastroenterol Hepatol 19: 278\u2013282","journal-title":"J Gastroenterol Hepatol"},{"key":"BFncpgasthep0654_CR34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0016-5107(02)70431-8","volume":"56","author":"A Andriulli","year":"2002","unstructured":"Andriulli A  et al. (2002) Gabexate or somatostatin administration before ERCP in patients at high risk for PEP: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 56: 488\u2013495","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR35","first-page":"41","volume":"4","author":"A Andriulli","year":"2003","unstructured":"Andriulli A  et al. (2003) Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. JOP 4: 41\u201348","journal-title":"JOP"},{"key":"BFncpgasthep0654_CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2036.1992.tb00543.x","volume":"6","author":"TP Kemmer","year":"1992","unstructured":"Kemmer TP  et al. (1992) Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995). Aliment Pharmacol Ther 6: 41\u201350","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep0654_CR37","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1365-2036.1998.00414.x","volume":"12","author":"Z Tulassay","year":"1998","unstructured":"Tulassay Z  et al. (1998) Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Aliment Pharmacol Ther 12: 1109\u20131112","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep0654_CR38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2036.2001.01015.x","volume":"15","author":"PA Testoni","year":"2001","unstructured":"Testoni PA  et al. (2001) Octreotide 24-h prophylaxis in patients at high risk for PEP: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther 15: 965\u2013972","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep0654_CR39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mge.2002.122614","volume":"55","author":"S Manolakopoulos","year":"2002","unstructured":"Manolakopoulos S  et al. (2002) Octreotide versus hydrocortisone versus placebo in the prevention of PEP: a multicenter randomized controlled trial. Gastrointest Endosc 55: 470\u2013475","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(00)70377-4","volume":"51","author":"A Andriulli","year":"2000","unstructured":"Andriulli A  et al. (2000) Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 51: 1\u20137","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1590-8658(01)80077-3","volume":"33","author":"G Cavallini","year":"2001","unstructured":"Cavallini G and Frulloni L (2001) Somatostatin and octreotide in acute pancreatitis: the never-ending story. Dig Liver Dis 33: 192\u2013201","journal-title":"Dig Liver Dis"},{"key":"BFncpgasthep0654_CR42","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1055\/s-2001-16520","volume":"33","author":"A Budzynska","year":"2001","unstructured":"Budzynska A  et al. (2001) A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 33: 766\u2013772","journal-title":"Endoscopy"},{"key":"BFncpgasthep0654_CR43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1572-0241.1999.999_u.x","volume":"94","author":"GD De Palma","year":"1999","unstructured":"De Palma GD and Catanzano C (1999) Use of corticosteriods in the prevention of PEP: results of a controlled prospective study. Am J Gastroenterol 94: 982\u2013985","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0654_CR44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1572-0241.1998.061_c.x","volume":"93","author":"JA Dumot","year":"1998","unstructured":"Dumot JA  et al. (1998) Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol 93: 61\u201365","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0654_CR45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mge.2003.307","volume":"58","author":"S Sherman","year":"2003","unstructured":"Sherman S  et al. (2003) Does prophylactic administration of corticosteroid reduce the risk and severity of PEP: a randomized, prospective, multicenter study. Gastrointest Endosc 58: 23\u201329","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0016-5107(05)01572-5","volume":"62","author":"P Mosler","year":"2005","unstructured":"Mosler P  et al. (2005) Oral allopurinol does not prevent the frequency or the severity of PEP. Gastrointest Endosc 62: 245\u2013250","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0016-5107(04)02647-1","volume":"61","author":"P Katsinelos","year":"2005","unstructured":"Katsinelos P  et al. (2005) High-dose allopurinol for prevention of PEP: a prospective randomized double-blind controlled trial. Gastrointest Endosc 61: 407\u2013415","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5107(05)01574-9","volume":"62","author":"P Katsinelos","year":"2005","unstructured":"Katsinelos P  et al. (2005) Intravenous N-acetylcysteine does not prevent PEP. Gastrointest Endosc 62: 105\u2013111","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2362.1991.tb01374.x","volume":"21","author":"P Toulon","year":"1991","unstructured":"Toulon P  et al. (1991) Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase\u2013antiproteinase interaction during acute pancreatitis in man. Eur J Clin Invest 21: 303\u2013309","journal-title":"Eur J Clin Invest"},{"key":"BFncpgasthep0654_CR50","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1067\/mge.2002.122616","volume":"55","author":"T Rabenstein","year":"2002","unstructured":"Rabenstein T  et al. (2002) Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 55: 476\u2013483","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0016-5107(04)00159-2","volume":"59","author":"T Rabenstein","year":"2004","unstructured":"Rabenstein T  et al. (2004) Low-molecular-weight heparin does not prevent acute PEP. Gastrointest Endosc 59: 606\u2013613","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gut.43.3.408","volume":"43","author":"JL Van Laethem","year":"1998","unstructured":"Van Laethem JL  et al. (1998) Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 43: 408\u2013413","journal-title":"Gut"},{"key":"BFncpgasthep0654_CR53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/gast.2001.21172","volume":"120","author":"J Deviere","year":"2001","unstructured":"Deviere J  et al. (2001) Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 120: 498\u2013505","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0654_CR54","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/j.1572-0241.2001.04092.x","volume":"96","author":"JA Dumot","year":"2001","unstructured":"Dumot JA  et al. (2001) A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol 96: 2098\u20132102","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0654_CR55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJM199609263351302","volume":"335","author":"G Cavallini","year":"1996","unstructured":"Cavallini G  et al. (1996) Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy\u2014Italian Group. N Engl J Med 335: 919\u2013923","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0654_CR56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0016-5107(02)70431-8","volume":"56","author":"A Andriulli","year":"2002","unstructured":"Andriulli A  et al. (2002) Gabexate or somatostatin administration before ERCP in patients at high risk for PEP: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 56: 488\u2013495","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR57","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1055\/s-2002-23629","volume":"34","author":"EL Fogel","year":"2002","unstructured":"Fogel EL  et al. (2002) Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 34: 280\u2013285","journal-title":"Endoscopy"},{"key":"BFncpgasthep0654_CR58","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1572-0241.2002.05829.x","volume":"97","author":"GC Harewood","year":"2002","unstructured":"Harewood GC and Baron TH (2002) An assessment of the learning curve for precut biliary sphincterotomy. Am J Gastroenterol 97: 1708\u20131712","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0654_CR59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-2007-993721","volume":"30","author":"Y Komatsu","year":"1998","unstructured":"Komatsu Y  et al. (1998) Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases. Endoscopy 30: 12\u201317","journal-title":"Endoscopy"},{"key":"BFncpgasthep0654_CR60","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(96)11026-6","volume":"349","author":"JJ Bergman","year":"1997","unstructured":"Bergman JJ  et al. (1997) Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bile duct stones. Lancet 349: 1124\u20131149","journal-title":"Lancet"},{"key":"BFncpgasthep0654_CR61","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/gut.52.8.1165","volume":"52","author":"P Vlavianos","year":"2003","unstructured":"Vlavianos P  et al. (2003) Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial. Gut 52: 1165\u20131169","journal-title":"Gut"},{"key":"BFncpgasthep0654_CR62","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1053\/j.gastro.2004.07.017","volume":"127","author":"JA Disario","year":"2004","unstructured":"Disario JA  et al. (2004) Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology 127: 1291\u20131299","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0654_CR63","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0016-5107(93)70217-5","volume":"39","author":"A Smithline","year":"1993","unstructured":"Smithline A  et al. (1993) Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 39: 652\u2013657","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR64","first-page":"1614","volume":"90","author":"S Sherman","year":"1995","unstructured":"Sherman S  et al. (1995) Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy induced pancreatitis? [abstract] Am J Gastroenterol 90: 1614","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0654_CR65","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0016-5085(98)70031-9","volume":"115","author":"PR Tarnasky","year":"1998","unstructured":"Tarnasky PR  et al. (1998) Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 115: 1518\u20131524","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0654_CR66","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1067\/mge.2003.124","volume":"57","author":"A Fazel","year":"2003","unstructured":"Fazel A  et al. (2003) Does a pancreatic duct stent prevent PEP? A prospective randomized study. Gastrointest Endosc 57: 291\u2013294","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR67","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0016-5107(04)02013-9","volume":"60","author":"P Singh","year":"2004","unstructured":"Singh P  et al. (2004) Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 60: 544\u2013550","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR68","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0016-5107(04)00353-0","volume":"59","author":"ML Freeman","year":"2004","unstructured":"Freeman ML and Guda NM (2004) Prevention of PEP: a comprehensive review. Gastrointest Endosc 59: 845\u2013864","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR69","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.gie.2005.04.046","volume":"62","author":"E Goldberg","year":"2005","unstructured":"Goldberg E  et al. (2005) Pancreatic-duct stent placement facilitates difficult common bile duct cannulation. Gastrointest Endosc 62: 592\u2013596","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gie.2006.01.058","volume":"64","author":"S Brackbill","year":"2006","unstructured":"Brackbill S  et al. (2006) A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc 64: 45\u201352","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR71","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1542-3565(04)00062-X","volume":"2","author":"A Rashdan","year":"2004","unstructured":"Rashdan A  et al. (2004) Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2: 322\u2013329","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFncpgasthep0654_CR72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0016-5107(03)02530-6","volume":"59","author":"ML Freeman","year":"2004","unstructured":"Freeman ML  et al. (2004) Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 59: 8\u201314","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR73","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0016-5107(96)70163-3","volume":"44","author":"MT Smith","year":"1996","unstructured":"Smith MT  et al. (1996) Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 44: 268\u2013275","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR74","first-page":"AB201","volume":"57","author":"S Michopoulos","year":"2003","unstructured":"Michopoulos S  et al. (2003) First intention of the biliary tree cannulation by means of a sphincterotome and a hydrophilic guidewire is a low risk-high success rate ERCP method [abstract]. Gastrointest Endosc 57: AB201","journal-title":"Gastrointest Endosc"},{"key":"BFncpgasthep0654_CR75","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0016-5107(04)00363-3","volume":"59","author":"F Lella","year":"2004","unstructured":"Lella F  et al. (2004) A simple way of avoiding PEP. Gastrointest Endosc 59: 830\u2013834","journal-title":"Gastrointest Endosc"}],"container-title":["Nature Clinical Practice Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0654","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:04:26Z","timestamp":1684440266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpgasthep0654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":75,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["BFncpgasthep0654"],"URL":"https:\/\/doi.org\/10.1038\/ncpgasthep0654","relation":{},"ISSN":["1743-4378","1743-4386"],"issn-type":[{"value":"1743-4378","type":"print"},{"value":"1743-4386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}